Analytics pros more than just 'quants,' says study

Share this article:
Market research departments of a number of life science companies incorporate analytics functions, either partially or fully, a study shows. These functions run the gamut from forecasting and sales force analytics to competitive intelligence and market sizing, along with eight others.

While analytics pros are vital, they're a misunderstood lot.

“People think of analytics as just number crunching. There's so much qualitative involved,” said Rob Naylor, senior analyst at Best Practices, LLC, which ran the study to identify models around which companies can build and maximize the business value of market analytics.  

One way involves staffing. The number of full-time employees required varied among the 21 firms. Proper staffing levels depend on several variables including product lifecycle. A well-established blockbuster may require one full-timer, while a Phase III candidate, three.

Another useful tactic: positioning. At one company, all 12 analytics functions were housed in one department. At another, the 12 were divided among seven. While each style has its advantages, in general, “It's good to integrate as many functions as you can to eliminate duplication,” said Haswell.
Bottom line: analytics has to be a core competency, with market conditions and pipelines determining to what degree this function grows.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?